Publications

5674 Results

A phase III randomized study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon-a2b for resected high-risk melanoma (U.S. Intergroup E1609): preliminary safety and efficacy of the ipilimumab arms

Authors
A Tarhini;SJ Lee;FS Hodi;UNM Rao;GI Cohen;O Hamid;L Hutchins;JA Sosman;HM Kluger;VK Sondak;HB Koon;DP Lawrence;K Kendra;DR Minor;CB Lee;MR Albertini;LE Flaherty;TM Petrella;JM Kirkwood
Journal / Conference
J Clin Oncol 35, 2017 (suppl; abstr 9500); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), oral presenation
Year
2017
Research Committee(s)
Melanoma
Study Number(s)
CTSU/E1609

Phase II study of the FGFR inhibitor AZD4547 in previously treated patients with FGFR pathway-activated stage IV squamous cell lung cancer (sqNSCLC): lung-map sub-study SWOG S1400D

Authors
C Aggarwal;M Redman;P Lara;H Borghaei;P Hoffman;JD Bradley;K Griffin;J Miao;PC Mack;V Papadimitrakopoulou;R Herbst;K Kelly;D Gandara
Journal / Conference
J Clin Oncol 35 (suppl; abstr 9055); ASCO Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
Year
2017
Research Committee(s)
Lung
Study Number(s)
S1400D

Phase III randomized study of 4 weeks of high-dose interferon-a-2b in stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) melanoma: a trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E1697)

Authors
S Agarwala;SJ Lee;W Yip;U Rao;A Tarhini;G Cohen;D Reintgen;T Evans;J Brell;M Albertini;M Atkins;S Dakhil;R Conry;JA Sosman;L Flaherty;V Sondak;WE Carson;M Smylie;A Pappo;R Kefford;J Kirkwood
Journal / Conference
Journal of Clinical Oncology Mar 10;35(8):885-892
Year
2017
Research Committee(s)
Melanoma
PMID
PMID28135150
PMC
PMC5455684
Study Number(s)
CTSU/E1697

Phase I Trial of Cediranib in combination with cisplatin and pemetrexed in chemonaive patients with unresectable malignant pleural mesothelioma (SWOG S0905)

Authors
AS Tsao;J Moon;I Wistuba;N Vogelzang;G Kalemkerian;M Redman;D Gandara;K Kelly
Journal / Conference
Journal of Thoracic Oncology Aug;12(8):1299-1308; Jun 6 [Epub ahead of print]
Year
2017
Research Committee(s)
Lung
PMID
PMID28599887;PMC5690479
Study Number(s)
S0905

A pooled analysis of individual patient data of concurrent chemoradiotherapy for stage 3 non-small-cell lung cancer in elderly patients compared to younger patients who participated in United States National Cancer Institute Cooperative Group studies

Authors
T Stinchcombe;Y Zhang;E Vokes;J Schiller;J Bradley;K Kelly;W Curran;SE Schild;B Movsas;G Clamon;R Govindan;G Blumenschein;M Socinski;N Ready;WL Akerley;HJ Cohen;H Pang;X Wang
Journal / Conference
Journal of Clinical Oncology Sep 1;35(25):2885-2892
Year
2017
Research Committee(s)
Lung
PMID
PMID28493811
PMC
PMC5578390
Study Number(s)
S0023

Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era

Authors
S Mantha;DA Goldman;SM Devlin;J Lee;D Zannino;M Collins;D Douer;HJ Iland;MR Litzow;EM Stein;F Appelbaum;RA Larson;R Stone;B Powell;S Geyer;K Laumann;JM Rowe;H Erba;S Coutre;M Othus;J Park;PH Wiernik;M Tallman
Journal / Conference
Blood Mar 30;129(13):1763-1767
Year
2017
Research Committee(s)
Leukemia and Lymphoma
PMID
PMID28082441
PMC
PMC5374291
Study Number(s)
C9710, E2496, S0521

Surrogate endpoints for overall survival in loco-regionally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis

Authors
F Rotolo;J Pignon;J Bourhis;S Marguet;J Leclercq;WT Ng;J Ma;ATC Chan;P-Y Huang;G Zhu;DTT Chua;Y Chen;H-Q Mai;DLW Kwong;YL Soong;J Moon;Y Tung;K-H Chi;G Fountzilas;L Zhang;E Hui;AWM Lee;P Blanchard;S Michiels
Journal / Conference
Journal of the National Cancer Institute, Apr;109(4). pii: djw239.
Year
2017
Research Committee(s)
Early Therapeutics and Rare Cancers and Head and Neck
PMID
PMID27927756
PMC
PMC6059121
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

What is the best treatment for locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis

Authors
L Ribassin-Majed;S Marguet;AWM Lee;WT Ng;J Ma;ACT Chan;P-Y Huang;G Zhu;T Chua;Q Chen;H-Q Mai;DL Kwong;C Shie-Lee;J Moon;Y Tung;K-H Chi;G Fountzilas;J Bourhis;J-P Pignon;P Blanchard
Journal / Conference
Journal of Clinical Oncology, Feb 35(5):499-505
Year
2017
Research Committee(s)
Early Therapeutics and Rare Cancers and Head and Neck
PMID
PMID27918720
PMC
PMC5791836
Study Number(s)
SWOG-8892 (INT-0099) (EST-2388) (RTOG-8817)

Patterns of growth factor usage and febrile neutropenia among older patients with diffuse large B-cell non-Hodgkin lymphoma treated with CHOP or R-CHOP: the Intergroup experience (CALGB 9793; ECOG-SWOG 4494)

Authors
VA Morrison;EA Weller;TM Habermann;S Li;RI Fisher;BD Cheson;BA Peterson
Journal / Conference
Leukemia & Lymphoma Aug;58(8):1814-1822
Year
2017
Research Committee(s)
Lymphoma
PMID
PMID27967294
PMC
PMC5502834
Study Number(s)
E4494

The 23-gene gene expression-based assay does not predict interim PET scan results after ABVD in advanced stage classical Hodgkin lymphoma in the US Intergroup S0816 trial

Authors
DW Scott;H Li;Y Harvey;F Chun Chan;A Mottok;M Boyle;AM Evens;H Schoder;DJ Strauss;N Bartlett;J Sweetenham;P Barr;M Fanale;ED Hsi;JR Cook;B Kahl;JP Leonard;JW Friedberg;M LeBlanc;C Steidl;R Gascoyne;L Rimsza;OW Press
Journal / Conference
International Conference on Malignant Lymphoma (June 14-17, 2017, Lugano, Switzerland), oral
Year
2017
Research Committee(s)
Lymphoma
Study Number(s)
S0816